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Making the (Business) Case for Clinical Ethics Support in the UK 
 
Abstract 
This paper provides a series of reflections on making the case to senior leaders for the introduction of 
clinical ethics support services within a UK hospital Trust at a time when clinical ethics committees are 
dwindling in the UK. The paper provides key considerations for those building a (business) case for 
clinical ethics support within hospitals by drawing upon published academic literature, and key reports 
from governmental and professional bodies. We also include extracts from documents relating to, and 
annual reports of, existing clinical ethics support within UK hospitals, as well as extracts from our own 
proposal submitted to the Trust Board. We aim for this paper to support other ethicists and/or health 
care staff contemplating introducing clinical ethics support into hospitals, to facilitate the process of 
making the case for clinical ethics support, and to contribute to the key debates in the literature around 
clinical ethics support. We conclude that there is a real need for investment in clinical ethics in the UK 
in order to build the evidence-base required to support the wider introduction of clinical ethics support 
into UK hospitals. Furthermore, our perceptions of the purpose of, and perceived needs met through, 
clinical ethics support needs to shift to one of hospitals investing in their staff. Finally, we raise 
concerns over the optional nature of clinical ethics support available to practitioners within UK 
hospital.  
 
Key words: Business case; Clinical ethics; Clinical ethics support; NHS  
 
Introduction 
This paper provides a series of reflections of an academic socio-ethicist’s (XY) and a senior clinician’s 
(XX) experiences of making the case for the introduction of Clinical Ethics Support Services (CESS) 
within a National Health Service (NHS) Trust. At the time of writing, no CESS was available within 
the local region for hospital- and community-based practitioners, despite extensive support from 
healthcare professionals across the Trust for the introduction of CESS. The paper will outline the 
journey of the academic being approached by the clinician to consider setting up a CESS at the Trust, 
to being faced with the daunting task of completing a business case, to working collaboratively with 
clinical colleagues to prepare a proposal to the Trust Executive Board. The reflections will focus on the 
drivers and agendas underpinning the aspiration to establish a CESS, and the emotions and reactions 
generated by preparing a proposal for the Trust. The paper will make reference to aspects of the 
hospital Trust’s business case template and how this was ‘translated’ and ‘interpreted’ when 
composing a proposal for a CESS. As such, this paper provides key considerations for those building a 
(business) case for CESS within NHS Trusts. We draw upon published academic literature, and key 
reports from governmental and professional bodies. We also include extracts from documents relating 
to, and annual reports of, existing CESS within NHS Trusts, as well as extracts from our own proposal 
submitted to the Trust Board. We aim for this paper to support other ethicists and/or health care staff 
contemplating introducing CESS into NHS Trusts, to facilitate the process of making the case for 
CESS, and to contribute to the key debates in the literature around CESS.  
 
Clinical ethics support in context 
In the late 1970s, clinical ethics emerged as an applied field of biomedical ethics, which focuses on 
individual cases within clinical practice and the practical consequences, for example the moral and 
ethical issues that arise out of the clinician-patient/family relationship (Solomon et al. 1991; Sulmasy 
2001; Thomasa 1994). Clinical ethics has therefore been described as “a discipline that aims to make 
ethical decisions more orderly, systematic and rational” and therefore “deals with concrete judgements 
in situations in which action must be taken despite uncertainty” (Pellegrino 1989). The aim of CESS 
then is to support healthcare professionals, hospital management, patients and relatives when 
confronted with an ethical concern, question or dilemma (Molewijk et al. 2016). CESS have been 
implemented differently in parts of the world and come in various forms including clinical ethics 
committees, clinical ethics consultants, rapid reviews, ethics drop-in sessions, moral case deliberation, 
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ethics reflection groups, ethics rounds, and seminars and conferences (Magelssen et al. 2016; Molewijk 
et al. 2016; UK CEN; Weidema et al. 2016). CESS typically have four functions: a) consultation on 
ethical issues relating to clinical cases b) participation in development of guidelines for good clinical 
practice c) education and d) reflection on ethical issues from the acute clinical setting (Andereck 1992; 
Førde and Pedersen 2011; Fost and Cranford 1985; Rosner 1985). The education function of CESS has 
predominately been served by seminars and conferences on clinical-ethical topics open to all hospital 
employees. Depending on the urgency of the support needed, the full committee, an individual clinical 
ethicist, or a subset of the full committee typically performs the ethics case consultations. Consultation 
can involve clarifying the value uncertainty or conflict involved and facilitating consensus. Most CESS 
offering case consultation assumes a non-directive, facilitative role in consultation (Tarzian et al. 
2013).  
 
The development of CESS had tended to start ‘bottom up’ (Slowther et al. 2012) and therefore the 
advent and spread of formal clinical ethics support is often described as a grassroots phenomenon. 
Clinicians who have requested CESS typically describe the experience as useful (Magelssen  et al. 
2016) and have tended to seek support for conflict resolution, reassurance about a decision, 
clarification of issues, new insights on a case, and emotional support (DuVal et al. 2001). However, a 
range of barriers have been reported that are thought to hinder clinicians engagement with CESS, 
including the perceptions of consultations as difficult to access, time consuming and/or intimidating 
(Sokol 2009). Equally, some clinicians are simply unaware of the service, or fear that a committee will 
worsen the situation (Gaudine et al. 2011) or mean losing their autonomy in making decisions over a 
clinical case (Orlowski  et al. 2006). CESS have also been accused of being too remote from the daily 
activities of healthcare or of being ill-equipped to handle the ethical challenges that are most pressing 
(Bayley 2006; McCruden and Kuczewski 2006). 
 
CESS began in America and are available internationally, including France, Belgium, Netherlands, 
Germany, Italy, Switzerland, Croatia, Lithuania, Bulgaria, Israel, and Japan (McGee et al. 2001; Simon 
2001; Slowther et al. 2001). CESS in the United Kingdom (UK) provides a unique case when 
contemplating CESS globally. Typically CESS in the UK has tended to be organised around clinical 
ethics committees, and seminars and conferences, whereas Scandinavian countries and the Netherlands 
have witnessed the rise of moral case deliberation and ethics reflection groups, and American hospitals 
usually have a clinical ethicist on hand for rapid reviews. Furthermore, CESS in UK is different to 
other countries such as America, Belgium and Norway, as it is not a legal requirement for all NHS 
hospitals to have CESS available (Magelssen et al. 2016). The establishment of CESS in the UK and 
Europe has been slower than in America (Thornton and Lilford 1995), and until recently the demand 
for CESS was growing (Mayor 2005; Slowther et al. 2001; Sokol 2005), with at least 82 NHS hospitals 
providing CESS to their staff in 2010 (Slowther et al. 2012). However, recent figures on the UK 
Clinical Ethics Network (UKCEN) membership (Austin 2018) suggest that doctors’ access to CESS 
has become limited, as the number of registered CESS with UKCEN has decreased. A worrying 
finding for healthcare professionals facing ethical and moral challenges within a NHS that is under 
immense financial strain (Morley et al. 2019) and delivering care at a time of great political uncertainty 
nationally and internationally.  
 
A need for clinical ethics support in the UK 
With such limited formal support available, healthcare professionals in the UK are reported to most 
frequently access support from senior colleagues and their peers when dealing with clinical ethical 
dilemmas. Yet, a report from the Royal College of Physicians showed the limitations with such an 
approach for those needing support, 
“…there was an overwhelming impression that consultants did not necessarily have the broad 
understanding of ethical issues, and in particular the bioethical and legal framework 
surrounding ethical decisions to act as an entirely safe resource for junior doctors” (Royal 
College of Physicians 2005)  
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Moreover, it has been shown that clinicians often lack ethical sensitivity, failing to identify that a 
difficult issue or case has an ethical as well as a clinical component (McLean 2009). For some UK 
Foundation Doctors within the first two years of practice since finishing medical school, this means an 
absence of role models to serve as moral and practical guides (McDougall and Sokol 2008). These 
problems could be symptomatic of the lack of ethical and legal training available once doctors qualify. 
Medical schools cannot be expected to prepare tomorrow’s doctors for all the ethical and legal 
challenges they will face after graduation (Machin et al. 2020). After all, there is a world of difference 
between discussing ethical problems in the relative safety of a seminar, and acting ethically where the 
implications suddenly become real (Sokol 2010). At present, the training Foundation Doctors receive 
has a significant emphasis on technical and clinical competencies (Linklater 2010) and limited content 
on ethics and law topics (Benson 2014; Levy and Coward, 2010) in order to be better prepared to 
respond to the ethical uncertainty they face in the first two years after medical school (Machin et al. 
2020). However, as others have identified, no members of a healthcare team, irrespective of their 
seniority, are immune from being faced with ethical dilemmas (Larcher et al. 1997) suggesting a need 
for ethics and law training and education to be available at all stages of career development (Guillemin 
et al. 2009). 
 
Recognising a need for clinical ethics support in one NHS Trust 
Clinical colleagues from a hospital Trust in the North West of England help to facilitate clinical ethics 
workshops, and grade clinical ethics coursework at their local medical school where medical students 
learn, apply and critique clinical ethics frameworks to their own and others’ cases. Clinical colleagues 
appreciate the opportunity to be involved in such activities as they acknowledge that they had not 
received such in-depth ethical training when they attended medical school compared to current medical 
students as others have noted elsewhere (Demir and Büken 2016). Senior clinicians also feel the weight 
of expectations upon them to be able to support junior colleagues when facing ethical and legal 
challenges, yet are often uncertain how to approach and resolve their own as well as others’ ethical 
dilemmas.  
 
One particular teaching activity within the medical school are the Clinical Ethics Forums, which 
introduce the concept of clinical ethics support to Social Work, Medicine, and Clinical Psychology 
students (Machin et al. 2019). The Forums are multiprofessional to reflect the membership of real-life 
Clinical Ethics Committees, and students use common ethical frameworks, such as Four Principles 
(Beauchamp & Childress 1989), Four Quadrants (Jonsen et al. 1982), and Seedhouse Grid (Seedhouse 
2009), to analyse and discuss their own dilemmas they have experienced during their training. For the 
clinical colleagues that facilitate the student Clinical Ethics Forums, it confirmed the gap in the support 
available to them when facing ethical uncertainty in their clinical practice, as well as highlighted how 
support could be available within their Trust.  
 
The recognition of support needed in order to overcome the felt isolation when deciding how to 
proceed in the face of ethical uncertainty was consolidated after a phone call took place between the 
authors of the paper (herein referred to as ‘we’, ‘us’, or by our initials) to discuss a particularly 
troubling case together. During the phone call, XX outlined key aspects of the case, and responded to 
XY’s prompts and queries in order to get a better sense of where the value conflicts lay. In 
collaboration, the significant ethical, legal and professional elements of the case were identified and 
explored, and possible next steps on how to proceed were considered. The decision to explore clinical 
ethics support via a clinical ethics committee within the Trust was made, and what follows is a brief 
overview of the steps taken at the time of writing.  
 
Establishing the case for CESS in one NHS Trust 
We decided to hold a meeting outside typical work hours with key players within the hospital Trust 
invited including the Chief Executive Nurse, Legal Advisor, Clinical and Nursing Leads, Research and 
Development Director, and End of Life Representatives. A Trustee from the UKCEN attended and 
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presented at the meeting, who also had experience of clinical ethics committee work and acted as a 
clinical ethicist also in the North of England. The purpose of the meeting was to gauge if employees 
within the Trust also deemed a need for CESS, and if so, to widen the circle of involvement, and 
expand the core of interested people. The idea being that if staff had learned about the CESS through 
their respected colleagues, and had contributed to developing the innovation through early discussions, 
then this may foster future engagement in the CESS if implemented as others have highlighted (Rogers 
1983; Wilkerson and Maxwell 1988). We also learned of the importance of co-ownership and co-
production for users of future CESS from Scandinavian countries and the Netherlands and their use and 
implementation of moral case deliberation (de Snoo-Trimp et al. 2017) and therefore we explored 
various formats and functions of a CESS. At the end of the meeting, there was sufficient support and 
interest in establishing a CESS, and agreement from attendees to take the idea of establishing a clinical 
ethics committee in the first instance forward to senior leaders within the Trust.  
 
The initial response from the senior leaders was to ask us to complete the hospital Trust’s business case 
template for the proposed clinical ethics committee. According to hospital Trust’s guidance, a business 
plan is, 
“a proposal that seeks authorisation from an appropriate decision-making Body for the 
allocation of resource associated with change to the business e.g. to deliver a new service…” 
(Trust guidance on completing a business case 2014) 
Within the Trust, any business case is reviewed and approved through a hierarchy of senior staff and 
committees, such as Clinical Director, Finance Committee, Trust Board, and then is either approved, 
with or without conditions, or rejected or recommended to be resubmitted following clarification of 
certain points. 
 
There is a long-standing culture of justification surrounding ‘ethics’ in medicine (Stirrat 2015) be that 
explaining the value of teaching ethics in ‘packed’ medical curriculums (Campbell et al. 2007; Nuffield 
Council on Bioethics 2014), or defending the time away from clinical duties for Foundation Doctors to 
receive training (Kirkham and Baker 2012). Most ethicists are therefore experienced in, and prepared 
to, ‘market’ the worth and value of ‘ethics’ (Papanikitas 2018). Yet, we could not find or access any 
business cases for existing UK CESS when first starting out, and using the internet search term 
‘business case for ethics’ unearthed material with limited content (see UKCEN 2014). Whilst we were 
inexperienced in writing business plans, and the length of the business plan template was unappealing, 
the real obstacle lay with the ‘evidence’ required to complete it, which is explained further below. 
 
The ‘evidence’ problem when completing a business case application for CESS  
Few commentators on CESS appear to seriously doubt their importance and utility, but as healthcare 
has become a field dominated by questions of performance, efficiency and cost effectiveness 
(Millstone 2014), ethics support appears to need to demonstrate its value to “justify adequate 
resourcing” (Royal College of Physicians 2005) and show that it does “not waste resources” (American 
Society for Bioethics and Humanities 2009). While it seems self evident that CESS in the institutional 
setting may improve the ethical dimension of patient care and so improve the overall quality of 
healthcare, evidence in support of this contention is hard to come by (UKCEN 2014). In particular, 
evidence that considers the efficiency of the ethics consultation through the cost savings that it 
generates (Bacchetta and Fins 1997; Daly 2000; Heilicser et al. 2000) or the effectiveness of the ethics 
consultation service through satisfaction studies (Tulsky and Fox 1996) is scarce.  
 
We searched the literature and found bold claims, espousing the many benefits of introducing CESS for 
healthcare organisations, including increasing patient satisfaction (Kaplan et al. 1989; Tierney et al. 
2001), and improving employee morale (Bischoff  et al. 1999), although it was not always clear if a 
direct causal relationship existed between these outcomes and the presence of a CESS. Others justified 
the moderate cost necessary for the running of any CESS by claims of improved efficiency and 
savings, and improvements in clinical quality and safety (Macdonald and Worthington 2012). For 
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example, effective CESS have been shown to improve quality of care and reduce length of stay and 
cost (Halloran et al. 1995). Such claims are supported in the wider business and management literature 
discussing the importance of developing a strong ethics culture within an organisation in order to 
improve performance, efficiency and productivity (Verschoor 1999). However, methodological 
obstacles exist in providing the evidence demanded by the business case application such as 
determining how to measure the ‘value’ of the support provided by the CESS (Schildmann et al. 2013), 
agreeing upon how it is ‘valued’ by the various stakeholders (de Snoo-Trimp et al. 2017), and how 
meaningful any analysis would be based on the low number of cases supported by the CESS (UKCEN 
2014).  
 
Exacerbating our challenge of completing the business case application were articles advising to stay 
clear from those few studies that attempted to construct the ‘evidence-base’ for CESS, particularly 
those that refer to the cost implications arising from ethical conflicts (see for example Nelson et al. 
2008) or the financial considerations for CESS (see for example Bacchetta and Fins 1997; Daly 2000; 
Heilicser et al. 2000). In the literature, we are advised that cost savings are not particularly meaningful 
in the absence of estimates of the costs of a service and, more importantly, do not capture the 
‘intangible benefits’ created by CESS (Mills et al. 2005). Instead, we are encouraged to focus on the 
value achieved through CESS’ contribution to the “overall good of the patient” (Repenshek 2017) and 
the intellectual capital (ethics knowledge) of CESS that create important, but intangible benefits, such 
as relieving ‘moral distress’ (Mills et al. 2005), improving communication and relationships between 
healthcare professionals (de Snoo-Trimp et al. 2017). An additional problem proposed with using cost 
savings as an outcome is the potential for the loss of trust if clinicians or patients come to perceive cost 
as the primary objective of introducing CESS into a Trust rather than supporting staff and patients 
when facing ethical uncertainty (ibid.). For example, the expressed aim of the CESS at Great Ormond 
Street Hospital (GOSH) “isn’t to avoid costly court battles or to save the NHS money. It’s about 
making the right decision for the right reasons” (GOSH 2017). That said, European researchers have 
pointed out the subtle, but important, distinction between the goals and outcomes of CESS when 
contemplating any financial benefits of CESS. For them, the drivers for CESS to be established and 
exist do not need to be linked with financial gains, but it is feasible and acceptable for financial 
benefits to result from CESS and for them to be acknowledged (Schildmann et al. 2013).    
 
We were uncertain of how next to proceed. We recognised the constraints we were working within – 
NHS funding crisis, age of austerity (Morley et al. 2019) - and had some sympathy with the need to 
justify spending on introducing CESS into the Trust. Equally, at the Trust, the main forum for 
discussion of ethical issues and dilemmas was within individual clinical units, although occasionally 
ethical aspects of particular cases were discussed at regular hospital clinical presentations e.g. Grand 
Rounds, Schwartz Rounds. Such discussions were considered ad hoc, unstructured, and constrained by 
time. Individual members of multidisciplinary teams tended to discuss issues within their own 
discipline and often with their peers, rather than with their seniors or juniors. Similar to other hospitals, 
there was a general view that this was unsatisfactory, as it could lead to tensions within teams and 
issues unresolved as others have noted elsewhere (Hamric and Wocial 2016). More public discussion 
of ethical issues away from acute clinical settings was therefore considered necessary and perceived as 
being achieved through introducing CESS that had consultative and educational functions, which other 
researchers have reported as beneficial (Larcher et al. 1997).  
 
The literature confirmed that healthcare staff need reflective spaces within institutions in which to 
explore and communicate values and ethical obligations as they undergird goals of patient care 
(Hamric and Wocial, 2016) and the CESS could play a role in creating and designing these spaces, and 
ensuring they remain “open, accessible and active” (Walker 1993). We therefore decided to pull out the 
key themes within the business case application and write a proposal instead that acknowledged them. 
This enabled us to use the evidence available within the literature, including making the argument to 
avoid using financial considerations as a deciding factor on whether to introduce CESS or not into the 
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Trust. However, the overwhelming financial focus of a business plan can generate a return on 
investment mindset for both the author and reader, and in turn the grandeur of claims surrounding the 
impact and influence of the proposed CESS can escalate. In order to demonstrate the ‘value’ and 
‘contribution’ of the proposed CESS in our proposal then, we felt inclined to identify and outline a 
number of problems that could be resolved via the CESS, which created another problem as described 
next.   
 
The ‘problem-solution’ problem when completing a business case application for CESS 
The challenge with ‘problems’ when making a business case for CESS is that the ‘problems’ cannot be 
seen to return. Instead they should be eradicated in order to justify and warrant the investment of 
funding into CESS. In effect, a business case application constructs a ‘problem-solution’ mindset 
whereby the author lays out a problem that needs resolving and identifies possible solutions. In the case 
of CESS, the discussion falls into ‘preventive’ ethics. Blake (2000) argues that CESS should be 
proactive to effect changes, rather than merely reacting to the cases that staff bring. The focus and 
purpose of CESS is then to influence and inform organisational culture. No longer is it the 
responsibility of one person or one group, but instead the responsibility of the whole institution that 
ethical practices are enacted. For example, the Ethics Program at the American hospital, Beth Israel 
Deaconess Medical Center in Boston, acts as a standing mechanism to influence and maintain a moral 
culture within the institution that, 
“helps to shift the influence of those who ‘do ethics’ in the institution to everyone who works 
here, whether at the bedside, in the laboratory or in the office. The programme enables us to 
enact our mission statement that ethics is part of everyone’s daily work” (Bates et al. 2017) 
Recent attention has been given in the literature to providing assistance with organisational ethics, 
whereby the ethical issues involved in areas such as management and resource allocation and quality 
improvement are worked through (Dorries et al. 2011; McClimans et al. 2012). This development 
responds to the critics of CESS who claim the crucial ethical issues at stake are general, structural, and 
organisational (Bayley 2006; McCruden and Kuczewski 2006). In essence, what each individual 
healthcare professional can and cannot do is arguably influenced by institutional policies and 
procedures, perceptions of legal liabilities, budgetary constraints, established patterns of 
communication and the tenor of the organisational culture (Solomon et al. 1991). It also reflects the rise 
in a ‘systems’ approach, whereby clinical ethics are fully integrated into the institution and wider 
healthcare apparatus (Fox et al. 2010; MacRae et al. 2008; Singer et al. 2001). CESS assist healthcare 
professionals in resolving value conflicts, whilst also improving respect for values such as autonomy 
and equity in practices at an organisational level (Dörries et al. 2011). For example, CESS can 
contribute to the development of patient-centred policies on end of life decisions and resuscitation or 
filming surgeries, and ensuring they are sufficiently responsive to patients’ preferences, and respect the 
dignity of patients (McClimans et al. 2011). CESS are therefore portrayed as providing ‘ethical 
leadership’ by improving the ethical environment and culture of the organisation (Magelssen et al. 
2016).  
 
The broader view required from the clinical ethicist when shifting focus to the ethical issues at an 
institutional level, means that it is possible to become aware of the recurring matters that come to the 
ethical committees. The cases highlight for clinical ethicists ‘gaps’ or other inadequacies in policies 
that need addressing, and where research is needed (Mill et al. 2005). Some commentators present 
these recurring ethical issues within an institution as the characters changing within a specific case, but 
the basic problem is the same (Dunn et al. 2016). Consequently, the role of CESS moves from merely 
‘reacting’ to ethical conflicts as they arise to pre-empting them and responding through a system-wide 
approach (ibid.). In a systems approach, ethics support moves ‘upstream’ to address systematic and 
structural elements that produce value conflict rather than remain only at the level of the particulars of 
the issue or case at hand. This encourages a more proactive and preventative form of ethics support 
(Fox et al. 2010; MacRae et al. 2008; Nelson et al. 2010). The ethical issues and difficulties are 
perceived as recurring expressions of problematic systemic structures and processes within and 
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between the micro and macro systems within an organisation. Essentially, the cases for the CESS are 
considered the ‘tip of the iceberg’ (New South Wales Government Health 2015).  
 
Addressing the recurring ethical challenges is important as these can create moral distress for the staff 
within the organisation. Positioning CESS as playing a role at both individual and institutional levels 
could be crucial as discussions could lead to development of ethics practice strategies to address and 
possibly decrease the stressful nature of ethical conflicts (Nelson 2009). Staff may feel at ease 
regarding a decision related to an ethical problem. Staff may be able to make decisions in the best 
interests of their patients, have their ideas about patient care considered in the care plan, or may be able 
to relieve or reduce patients’ pain and suffering (Corley and Minick 2002). The aspiration of creating 
moral comfort for staff is reflected in the aims of an active American CESS,  
“to promote a culture in which all BIDMC staff appreciate the importance of the ethical 
aspects of their work (their decisions, actions, character and morale), and have the support 
they need to do that work in accordance with BIDMC’s, and their own highest moral 
standards” (Bates et al. 2017) 
It is important to note within the literature that it is more likely that the emotions around the conflict are 
addressed and hopefully reduced, rather than the conflict itself. Arguably, knowing how to resolve a 
problem or having the means available to respond to a problem, does not mean that the problem itself 
ceases to exist, or that the response is flawed if it recurs, or that we will not ever have problems to 
respond to again in the future. The danger of the problem-solution mindset in a business case then is 
that the discussion becomes unrealistic, with promises of scandals averted, and conflicts and 
disagreement with next of kin or patients eradicated, thereby setting up CESS to ‘fail’. Resisting the 
temptation to make such promises was challenging when composing the proposal. The Trust itself had 
received negative publicity, with reports of dysfunctional teams, and poor standard of care within a 
number of departments (see for example Dyer 2019 and Goodwin 2019) and CESS have been 
implicitly presented by various stakeholders as a response to, and a way to prevent, the failings of the 
NHS healthcare system equating to poor patient care and safety. We briefly outline the challenges 
below.  
 
The problems with healthcare ‘scandals’ and CESS as the solution 
The first problem with the association between the ‘problem’ of poor teams and care practices and the 
‘solution’ of CESS was how it might influence how healthcare staff perceived CESS. It needed to be 
handled delicately in order for the CESS not to be perceived by healthcare staff as a ‘court of law’ that 
produced ‘ethical verdicts’ on clinical cases and on health professionals’ conduct, which others have 
claimed elsewhere (Pedersen  et al. 2009). Equally, such breaches of ethics in NHS Trusts without 
oversight and correction are arguably detrimental to a Trust’s reputation as well as financially (Dunn et 
al. 2016; Nelson et al. 2008). Hospital leaders have to consider carefully how they want to be perceived 
outside the organisation, so there may be reputational and branding benefits arising from introducing 
CESS into Trusts after such high profile scandals, inquiries and reports. With increasing concerns 
about the inhumane nature of some modern medicine (Weatherall 1994), CESS could promote 
reflection on ethical matters (Larcher et al. 1997), and could therefore be seen as responding to the 
needs of staff and patients. In turn, an effective CESS could make it easier to recruit and retain quality 
staff (Francis 2001).  
 
The second problem with the association of CESS with healthcare scandals was the lack of explicit 
recognition to the transformative influence of CESS in recent healthcare inquiry reports and 
recommendations. This is surprising given the specific problems identified in the reports such as 
dysfunctional team work and a lack of communication between multidisciplinary teams, crippling 
hierarchies and difficulty speaking up, professional obligations to a duty of candour – all of which 
could arguably be addressed through, and fall under the remit of, CESS (Carrese et al. 2012; Talash et 
al. accepted). At a minimum, members of CESS could role model the behaviours such as humility, 
respect for others, building positive relations, when facing ethical uncertainty (ibid.). CESS could also 
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help to establish the conditions for ethical reflection i.e. trust, role flexibility, and enquiry (Brown 
1990). So, on the one hand, whilst we were anxious to avoid the damaging impact upon staff’s 
engagement within CESS arising from the association of CESS as a response to healthcare scandals, 
we equally struggled to find explicit references that made the association on our behalf to highlight 
how CESS could address issues raised previously within the Trust.   
 
We therefore had to be creative and look to other sources. The UKCEN referred to the extensive 
failings observed in UK Trusts such as Mid Staffordshire, Basildon and Thurrock when making the 
case for CESS in the NHS (UKCEN 2014). Others have conveyed a similar message (see for example 
Beyleveld et al. 2002) including the Care Quality Commission (CQC) who monitors and inspects NHS 
Trusts to ensure people receive safe, compassionate and high quality care (CQC 2019). The CQC has 
recognised the important role of CESS in their reports when visiting hospitals where CESS exist, such 
as Great Ormond Street Hospital (GOSH), “The ethics committee was regularly available and played a 
key role in considering difficult treatment decisions” (GOSH 2017). This quote from the CQC is then 
followed within the GOSH CESS report by a warning, “It is worth remembering that the recent Francis 
Inquiry Report highlighted what can happen if these issues are not prioritized” (ibid.). 
 
In order to maximise this implicit association between healthcare scandals and CESS, we therefore 
considered the ideal time to share our proposal with the hospital Trust Executive Board would be ahead 
of an upcoming visit from the CQC. However, we wished to avoid staff perceiving the CESS as a 
mechanism of scrutiny (Førde et al. 2008; Gaudine et al. 2011; Slowther et al. 2001), to instil discipline 
or a form of punishment and therefore opted to share the proposal when it was completed. Following 
the lead of GOSH, we pitched our proposal as having the potential to positively impact upon the 
organisational culture through supporting staff, supporting the organisational vision, and meeting the 
government statement on patient decision making,  
“The introduction of CESS at [hospital Trust] will engage patients and their relatives in 
discussions when healthcare professionals make difficult healthcare decisions. Therefore the 
CESS supports [hospital Trust’s] desire to consistently deliver an excellent experience that 
exceeds patient and family expectations, as well as meeting the government’s vision for 
shared decision-making in healthcare: ‘no decision about me, without me’” (Extract from XY 
and XX Proposal for Clinical Ethics Support Service in NHS Hospital) 
We considered it less threatening to market the proposed CESS as a way of providing a reflective 
space, whereby the experiences of patients and relatives could be acknowledged and considered by 
healthcare staff, rather than reinforcing the association that can sometimes emerge between CESS and 
someone acting unethically (Carrese et al. 2012). The inclusion of CESS in the Trust would arguably 
therefore act as an explicit way of promoting shared decision-making, and in turn foster institutional 
awareness around ‘no decision about me, without me’. Implicitly, at an individual level, CESS had the 
potential to inform staff’s attitudes and perspectives, thereby acting as a form of staff development. To 
achieve this however, it required a shift in how we perceived CESS, in particular their roles and remits.  
 
The need for shifting perceptions when writing a business case for CESS 
As others have identified, doing clinical ethics needed to mean making ethical reflection an integral 
component of clinical practice, and an explicit part of the daily life of an organisation, and not just 
considered in the midst of, or in response to a crisis (Rubin and Zoloth 2004; Weidema et al. 2016). 
Yet, CESS have tended to be discussed around high profile or difficult cases, such as the Charlie Gard 
or Asha King in the UK (for example see Austin 2018), which has created a sense that everyday ethics 
do not warrant CESS. The ‘ethics of the ordinary’ are those situations that are part of everyday 
practice, that occur frequently, and cause a chronic feeling of moral distress (Corley and Minick 2002). 
Furthermore, there has been a tendency to focus CESS around medical specialisms, departments, 
and/or types of decisions or groups of patients, such as paediatrics (Gold et al. 2011; Larcher et al. 
1997), or intensive care (Schneiderman et al. 2003). However, ethical dilemmas arise frequently in 
clinical practice, irrespective of the type of unit or its area of speciality (Larcher et al. 1997). CESS 
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services are typically available within acute-care hospitals and as a result, support for community-
based practitioners when facing ethical uncertainty is less commonly implemented and therefore can be 
considered an under-serviced population. Small studies show where CESS have been piloted within 
community healthcare settings, respondents have overwhelmingly reported the services meeting their 
needs, typically dealing with everyday ethical issues revolving around patient autonomy, privacy, 
confidentiality and consent (Racine and Hayes 2006). 
 
These perceptions of when CESS are warranted may provide alternative explanations for the reported 
low referral of cases to UK CESS (Bates et al. 2017; Slowther et al. 2012), and the isolation and 
loneliness staff experience around ethically troubling matters. Reports of moral distress (Lamiani et al. 
2017; Oliver 2018), predominately focusing on nurses and beginning to be recognised in doctors, 
highlight that staff can be uncertain about what is the ethically appropriate action to take, and may keep 
this uncertainty to themselves, and not share their stress because they think they are alone in their 
uncertainty. Alternatively, staff may raise ethical questions, but feel unsupported in acknowledging 
their uncertainty and are without an available resource to share and discuss the issue. Equally, staff 
may know or believe an ethically appropriate course of action to take, but are unable to carry out the 
action because of an organisational obstacle (Lamiani et al. 2017; Nelson 2009).  
 
Such moral distress has consequences for healthcare organisations as it can negatively influence staff 
morale, confidence, sense of purpose, integrity, and respect for the organisation (Nelson 2009). It also 
has implications for the wider healthcare service as the higher the level of moral distress, the greater 
the likelihood of leaving a position (Hamric and Blackwell 2007; Oliver 2018), which is significant in 
the UK where we are informed that there are insufficient healthcare professionals to cope with patient 
demand (British Medical Association 2018; Kinman and Teoh 2018), and challenges exist around staff 
recruitment and/or retention in certain healthcare specialities (British Medical Association 2017; 
Chaudhuri et al. 2013). In the UK, the General Medical Council are conducting a review of the 
wellbeing of medical students and healthcare staff, and attempts are being made to support NHS staff 
through the provision of reflective spaces (see e.g. Gannon 2014) as recognition increases of the 
emotional burden that staff carry in their daily work (see e.g. Cornwell and Fitzsimons 2017; 
Kerasidou and Horn 2016;). We are also witnessing the resurgence of Schwartz Rounds (Goodrich 
2018) and the introduction of resilience training (Oliver 2018). Yet, some existing CESS describe 
themselves as providing “a space to give clinicians and families a place to discuss their concerns” 
(GOSH 2017), raising questions why staff have not approached CESS within their hospitals more 
frequently (Whitehead et al. 2009). Previously, underutilisation has been linked to a lack of 
understanding of the role of CESS (Bates et al. 2017) and how it might help (McLean 2009). Arguably, 
a mismatch may exist surrounding the perceived role – reflective space - and remit – ethics of the 
ordinary – of CESS between the providers and (potential) users of CESS. Collaborating with CESS 
could then become part of delivering everyday care, rather than staff approaching the service as a last 
resort (Hamric and Wocial 2016).   
 
Concluding thoughts 
Reflecting on the process of proposing CESS into an NHS Trust has highlighted two overarching 
points. Firstly, the significance of research when making the case for CESS emerged when faced with 
the business case application. Whilst drafting the proposal, we realised that the evidence available 
focusing on the UK context was limited, which might be a consequence of the voluntary nature and the 
lack of any specific requirement for UK healthcare organisations to have a mechanism for addressing 
ethical dimensions of the work. Historically, CESS have received little or no administrative support or 
funding, and members’ time has been given voluntarily meaning that any formal evaluation of CESS 
has been a lower priority for the sparse resources available (Steinkamp et al. 2007; UKCEN 2014). By 
searching for the evidence to fill a business case application, we became aware of the urgent need for 
up to date, empirical studies that analyse and evaluate the UK CESS experiences, which reflect the 
realities of facing an ethical dilemma within the NHS environment, and can enable sharing of good 
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practices from current CESS in UK. The empirical research needed should draw on both qualitative 
and quantitative data that goes beyond simple description and is of interest to a range of stakeholders 
including ethicists, healthcare professionals, patients and management (Schildmann et al. 2013). Singer 
et al. (1990) have described the ways in which empirical research can advance both theory and 
education in clinical ethics. We cannot underestimate the cultural context of discussions surrounding 
CESS and healthcare systems generally. In our experience, we were bolstered by the position that a 
lack of available evidence does not mean abandoning a good idea (New South Wales Government 
Health 2015). We realised that the CESS proposed could have a research function to it, and therefore 
fill some of the gaps in the UK evidence base. For example, we proposed being able to provide CESS 
that serves both hospital- and community-based practitioners, which would position our proposed 
CESS as a beacon for ethical, innovative and collaborative practice, and enable research into CESS that 
crosses practice boundaries. 
 
A second overarching point that emerged when making the case for CESS was the significance of how 
CESS is perceived by all parties in healthcare. Our experiences highlighted that for some NHS staff, 
limited support is available when they face ethical uncertainty, and some staff lack prior training on 
ethics and law to prepare them on how to deal with ethical uncertainty. Introducing CESS into a Trust 
therefore should be perceived as a form of staff investment. CESS can fill the current gap of ethics and 
law training after medical school in the UK. Our reflections have emphasised that clinical ethics 
training can benefit staff at all stages of their career, and the educational and training arm of CESS can 
therefore be viewed as supporting the continuing professional development of Trust staff (Hamric and 
Wocial 2016). Our reflections have also highlighted the perceived remit of CESS in the UK needs to 
evolve so that CESS can be seen as a source of everyday ethics support, which is causing moral 
distress, rather than solely for the high profile, and controversial cases, or after a Trust has been caught 
up in a healthcare ‘scandal’. It is worth noting that since the global pandemic of COVID19, the NHS 
Trust discussed in this paper, along with many others across the country, established a Clinical Ethics 
Advisory Group. However, whether these Groups continue beyond the pandemic remains to be seen. 
The pandemic has brought to light the value and need for CESS, but again the services are being 
utilised for the ‘extreme’ rather than the everyday ethical matters that arise from providing care. There 
is a real need to (re)educate those potentially engaging with and financially supporting CESS in the UK 
so that it is perceived as providing opportunities for ethical reflection and a space to share and gain – 
something achieved in Scandinavian countries and the Netherlands as witnessed by the increasing use 
of moral case deliberation within healthcare settings (de Snoo-Trimp et al. 2017). At a time when much 
controversy exists surrounding reflection for UK doctors (Dyer and Cohen 2018; Launer 2018), it is 
vital that the known benefits of ethical reflection, particularly within a group, are not overshadowed 
(Hem et al. 2018).   
 
In order to shift our perceptions of CESS, we do need to acknowledge the need for ethics support for 
the everyday challenges, for the senior as well as the junior staff members, for those working in the 
community, as well as in the hospital. If viewed in this way, CESS sends the message from the 
organisation that people matter (Levine 1977). Introducing CESS into a Trust can therefore be part of a 
package of support that meets the emotional and wellbeing needs of all staff. The role of CESS can 
therefore be perceived as building and fostering a community, exploring and developing opportunities 
for staff to share and talk to each other when facing everyday ethical uncertainty, and support 
organisations to develop policies and practices that promote ethical decision-making. When viewed in 
this way, the aims of the CESS can then be to reduce the ethical and emotional isolation reported by 
others (Nelson 2002; Oliver 2018) through providing support and training. Others have identified the 
need for organisations to ensure employee health programs are readily available to staff, so that 
employees can discuss in a confidential setting emotional issues arising in the work environment (Hem 
et al. 2018; Nelson 2009). There is no one size fits all however, and CESS should be viewed as part of 
a tool kit, that compliments existing, but different, support such as Schwartz Rounds and resilience 
training where they are available (Gannon 2014; Oliver 2018).   
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If CESS are perceived as investing in staff through providing continuing professional development and 
supporting emotional and wellbeing needs, any evaluation of CESS also needs to reflect this alternative 
perception. Some CESS use the level of engagement from all staff in activities relating to ethics within 
their clinical ethics program (Bates et al. 2017), whereas others consider ‘success’ as improving the 
level of ethical reflection among clinicians (Magelssen et al. 2016). When proposing introducing CESS 
into a Trust, we need to be prepared to reframe the ‘problem’ e.g. ethics and law training, ethical 
leadership, everyday ethical uncertainty, chronic low-level moral distress. So when facing the 
‘problem-solution’ mind-set generated by a business case application, our language can shift from an 
erasure and eradication of a ‘problem’, and importantly we can justify the constant and permanent 
presence of the CESS ‘solution’. By shifting our perception of the role, function, aims, and remit of 
CESS, we can better manage our own and other’s expectations surrounding CESS. We can reduce the 
‘hype’ around what CESS can deliver and achieve, which is generated when completing a business 
case application, and ultimately setting ourselves up to fail. Instead, the financial focus shifts to 
investment in our staff, patients, and healthcare system, through education, training, leadership, 
development, wellbeing and support. Whereas business plans demand timescales and deadlines, which 
set up a sense of finality and completion, the shift in our perceptions of CESS mean that we can see 
CESS as meeting on-going, lifelong needs. Just as these needs will evolve, so should the format and 
structure of CESS. Viewed in this way, we should all be greatly concerned at the dwindling number of 
CESS in the UK (Austin 2018), and question the optional nature surrounding NHS hospitals providing 
CESS for their staff and patients (Beyleveld et al. 2002; UKCEN 2014). As others have argued 
elsewhere, there is a need for the NHS to be viewed as a moral body, where its staff are part of a moral 
community, and make moral decisions on a daily basis, and they need support to do this (Austin 2007; 
UKCEN 2014). Healthcare institutions therefore have “ethical lives and characters just as their 
individual members do” (Reiser 1994), and therefore need to make a public commitment to ethical 
issues – which can be achieved through introducing CESS (Royal College of Physicians 2005; 
Solomon et al. 1991) – in order to fulfil its duty of care to their staff and patients (UKCEN 2014).  
 
In this paper, we have included extracts from our proposal submitted to the Board, we have outlined 
the issues that we considered when developing our proposal, as well as the evidence that we found and 
drew upon when making the case for CESS. We welcome dialogue with others interested in our full 
proposal and experiences. In the meantime, we offer some key considerations when making the case 
for CESS in the UK. Firstly, engage senior leaders and colleagues within the Trust early in the 
discussions around CESS and collaborate with senior leaders and colleagues within the Trust when 
designing CESS. Secondly, seek external support, advice and expertise. Approach established clinical 
ethics committees, involve ethicists at local medical schools, and draw on resources from formal 
clinical ethics networks. Thirdly, gather support from senior leaders within the Trust to work outside 
any paperwork expectations such as business case application when making the case. Be prepared to 
engage with the themes, but present the material in alternative formats that shift the discussion beyond 
simple economics, and the problem-solution approach. Fourthly, be realistic as to the goals and gains 
of CESS. Do not be tempted to overhype the impact and influence of CESS in order to secure support 
from senior leaders and colleagues. Understand and utilise the context that provides the backdrop to the 
CESS you are attempting to establish and be open and honest about it for example state that a lack of 
research on UK CESS exists, remind readers of the lack of ethics and law training nationally after 
medical school, and highlight the lack of UK CESS available for healthcare professionals to draw on. 
Fifthly, be mindful of your own and other’s expectations of CESS. Even when and where CESS exist, 
conflicts can still escalate, and can require legal intervention. As Somerville (2004) points out, do not 
be tempted to present CESS as a perfect system. When composing our proposal for introducing CESS 
into the hospital Trust, we therefore acknowledged some of the criticisms towards CESS within the 
literature and balanced them with the potential benefits of CESS, alongside the present reality in the 
Trust for staff and patients faced with ethical uncertainty and little formal support available. Sixthly, 
keep in mind the readers of your proposal. Others (see Dubov 2015; London 2000) have drawn on 
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Aristotle’s work, Rhetoric, in the context of healthcare and communication to highlight the importance 
and power of persuasion, 
 “people make choices and calculate associate risks not only based on what they think about an 
 option, but also on how they feel about it” (Dubov 2015) 
Therefore the emotion and needs of the readers can inform and influence how the proposal is written 
and how the option of a CESS is presented, without losing the integrity of the proposed CESS. Finally, 
we encourage others contemplating introducing CESS into their UK hospitals and going through a 
similar process to share their learnings so that we can build and share resources and materials when 




American Society for Bioethics and Humanities. 2009. Improving competence in clinical ethics 
consultation: An education guide. Glenview, IL: American Society for Bioethics and Humanities.  
 
Andereck, William S. 1992. Development of a hospital ethics committee: Lessons from five years of 
case consultations. Cambridge Quarterly of Healthcare Ethics 1: 41-50. 
 
Austin, Wendy. 2007. The ethics of everyday practice: Healthcare environments as moral 
communities. Advances in Nursing Science 30:  81-88. 
 
Austin, Louise. 2018. UK processes for resolution of disagreements about the care of critically ill 
children. http://nuffieldbioethics.org/project/disagreements-care-critically-ill-children/literature-
reviews/austin-l-2018-uk-processes-for-resolution-of-disagreements-in-care-of-critically-ill-children 
Accessed 15 March 2019.  
 
Bayley, Carol. 2006. Ethics committee DX: Failure to thrive. HEC Forum 18: 357-367. 
 
Bates, Sarah R., Wendy J. McHugh, Alexander R. Carbo, Stephen F. O'neill, and Lachlan Forrow. 
2017. The Ethics Liaison Program: Building a moral community. Journal of Medical Ethics 43: 595-
600. 
 
Bacchetta, Matthew D., and Joseph J. Fins. 1997. The economics of clinical ethics programs: A 
quantitative justification. Cambridge Quarterly of Healthcare Ethics 6: 451-460. 
 
Beauchamp, Tom L., and James F. Childress. 1989. Principles of biomedical ethics. Oxford: Oxford 
University Press. 
 
Benson, Madeleine Ruth. 2014. How prepared do foundation doctors perceive themselves to be to face 
medical ethical dilemmas encountered in practice? 
https://www.instituteofmedicalethics.org/website/images/resources/report%20m%20benson.pdf 
Accessed 18 January 2019. 
 
Beyleveld, Deryck, Roger Brownsword, and Susan Wallace. 2002. Clinical ethics committees: 
Clinician support or crisis management? HEC Forum 14: 13-25. 
 
Bischoff, Sheri J., Kristen Bell DeTienne, and Bruce Quick. 1999. Effects of ethics stress on employee 
burnout and fatigue: An empirical investigation. Journal of Health and Human Services Administration 
21: 512–32. 
 
Blake, David C. 2000. Reinventing the healthcare ethics committee. HEC Forum 12: 8-32. 
 
British Medical Association. 2017. The state of pre and post graduate medical recruitment in England 
https://www.bma.org.uk/collective-voice/policy-and-research/education-training-and-workforce/state-
of-medical-recruitment Accessed 24 April 2019. 
 
British Medical Association. 2018. Working in a system that is under pressure 
https://www.bma.org.uk/collective-voice/influence/key-negotiations/nhs-pressures/working-in-a-
system-under-pressure Accessed 24 April 2019. 
 
Brown, Marvin T. 1990. Working ethics: Strategies for decision making and organizational 
responsibility. San Francisco: Jossey-Bass. 
 14 
 
Campbell, Alastair V., Jacqueline Chin, and Teck-Chuan Voo. 2007. How can we know that ethics 
education produces ethics doctors? Medical Teacher 29: 431-436. 
 
Care Quality Commission. About us. What we do and how we do it https://www.cqc.org.uk/about-
us/our-purpose-role/who-we-are Accessed 25 April 2019. 
 
Carrese, Joseph A., Armand H. Antommaria, Kenneth A. Berkowitz, Jeffery Berger, Joseph Carrese, 
Brian H. Childs, Arthur R. Derse, Colleen Gallagher, John A. Gallagher, Paula Goodman-Crews, and 
Ann Heesters. 2012. HCEC pearls and pitfalls: Suggested do's and don'ts for healthcare ethics 
consultants. The Journal of Clinical Ethics 23: 234-240. 
 
Chaudhuri, Ella, Nicola C. Mason, Nina Newbery, and Andrew F. Goddard. 2013. Career choices of 
junior doctors: Is the physician an endangered species? Clinical Medicine 13: 330-335. 
 
Corley, Mary C., and Ptlene Minick. 2002. Moral distress or moral comfort. Bioethics Forum 18: 7-14.  
 
Cornwell, Jocelyn, and Bev Fitzsimons. 2017. Behind Closed Doors. The Point of Care Foundation. 
https://www.pointofcarefoundation.org.uk/evidence/behind-closed-doors/ Accessed 25 April 2019 
 
Daly, Gail. 2000. Ethics and economics. Nursing Economics 18: 194 – 201. 
 
Demir, Müge, and Nüket Örnek Büken. 2016. Proposal for a Hospital Ethics Committee at the 
Hacettepe University Hospitals, Turkey: A Mixed Methods Study. Acta Medica Anatolia 4: 21 – 31. 
 
Dörries, Andrea, Pierre Boitte, Ana Borovecki, Jean-Philippe Cobbaut, Stella Reiter-Theil, and Anne-
Marie Slowther. 2011. Institutional challenges for clinical ethics committees. HEC Forum 23: 193 – 
205. 
 
Dubov, Alex. 2015. Ethical persuasion: the rhetoric of communication in critical care. Journal of 
Evaluation in Clinical Practice 21: 496 – 502. 
 
Dunn, Edward J., Marks, Adam D., and Tenner, Laura. 2016. Good ethical policies can empower 
clinicians and improve bottom line:  
https://www.reliasmedia.com/articles/137392-good-ethical-policies-can-empower-clinicians-and-
improve-bottom-line Accessed 5 June 2019. 
 
DuVal, Gordon, Leah Sartorius, Brian Clarridge, Gary Gensler, and Marion Danis. 2001. What triggers 
requests for ethics consultations? Journal of Medical Ethics 27: i24-i29. 
 
Dyer, Clare. 2019. Unredacted report reveals patient safety concerns at “dysfunctional” Morecambe 
Bay urology unit. British Medical Journal 365: l2352. 
 
Dyer, Clare, and Deborah Cohen. 2018. How should doctors use e-portfolios in the wake of the Bawa-
Garba case?. British Medical Journal 360: k572. 
 
Francis, Ronald D. 2001. Evidence for the value of ethics. Journal of Financial Crime 9: 26–30. 
 
Førde, Reidun, and Reidar Pedersen. 2011. Clinical ethics committees in Norway: What do they do, 
and does it make a difference? Cambridge Quarterly of Healthcare Ethics 20: 389-395. 
 
 15 
Førde, Reidun, Reidar Pedersen, and Victoria Akre. 2008. Clinicians’ evaluation of clinical ethics 
consultations in Norway: A qualitative study. Medicine, Health Care and Philosophy 11: 17-25. 
 
Fost, Norman, and Ronald E. Cranford. 1985. Hospital ethics committees: Administrative aspects. 
Journal of American Medical Association 253: 2687-2692. 
 
Fox, Ellen, Melissa M. Bottrell, Kenneth A. Berkowitz, Barbara L. Chanko, Mary Beth Foglia, and 
Robert A. Pearlman. 2010. IntegratedEthics: An innovative program to improve ethics quality in health 
care. Innovation Journal 15: 1-36. 
 
Gannon, Craig. 2014. Contrasting Schwartz Rounds with clinical ethics: Three perspectives on their 
potential to impact on end-of-life care. Nursing Ethics 21: 621-623. 
 
Gaudine, Alice, Marianne Lamb, Sandra M. LeFort, and Linda Thorne. 2011. Barriers and facilitators 
to consulting hospital clinical ethics committees. Nursing Ethics 18: 767-780. 
 
Gold, Hugo, Georgina Hall, and Lynn Gillam. 2011. Role and function of a paediatric clinical ethics 
service: Experiences at the Royal Children's Hospital, Melbourne. Journal of Paediatrics and Child 
Health 47: 632-636. 
 
Goodrich, Joanna. 2018. Our impact: The Schwartz Rounds programme. 
https://www.pointofcarefoundation.org.uk/evidence/impact-schwartz-rounds-programme/ Accessed 24 
April 2019. 
 
Goodwin, Dawn S. 2019. NHS Inquiries and the Problem of Culture. The Political Quarterly. 
https://doi.org/10.1111/1467-923X.12693 
 
Great Ormond Street Hospital for Children. 2017. 1st Clinical Ethics Service Report: 
file:///C:/Users/machinl/AppData/Local/Microsoft/Windows/INetCache/IE/BTLQBCZ7/1st%20Clinica
l%20Ethics%20Service%20Report_19%20July%202017.pdf Accessed 19 April 2019. 
 
Guillemin, Marilys, Rosalind McDougall, and Lynn Gillam. 2009. Developing “ethical mindfulness” in 
continuing professional development in healthcare: Use of a personal narrative approach. Cambridge 
Quarterly of Healthcare Ethics 18: 197-208. 
 
Hamric, Ann B., and Leslie J. Blackhall. 2007. Nurse-physician perspectives on the care of dying 
patients in intensive care units: Collaboration, moral distress, and ethical climate. Critical Care 
Medicine 35: 422-429. 
 
Hamric, Ann B., and Lucia D. Wocial. 2016. Institutional ethics resources: Creating moral 
spaces. Hastings Center Report 46: S22-S27. 
 
Heilicser, Bernard J., David Meltzer, and Mark Siegler. 2000. The effect of clinical medical ethics 
consultation on healthcare costs. The Journal of Clinical Ethics 11: 31-38. 
 
Hem, Marit H., Bert Molewijk, Elisabeth Gjerberg, Lillian Lillemoen, and Reidar Pedersen. 2018. The 
significance of ethics reflection groups in mental health care: a focus group study among health care 
professionals. BMC Medical Ethics 19 https://doi.org/10.1186/s12910-018-0297-y 
 
Jonsen, Albert R., Mark Siegler, and William J. Winslade. 1982. Clinical ethics: A practical approach 
to ethical decisions in clinical medicine. York: Macmillian. 
 16 
 
Kaplan, Sherrie H., Sheldon Greenfield, and John E. Ware Jr. 1989. Assessing the effects of physician-
patient interactions on the outcomes of chronic disease. Medical Care 27: S110–S127. 
 
Kerasidou, Angeliki, and Ruth Horn. 2016. Making space for empathy: Supporting doctors in the 
emotional labour of clinical care. BMC Medical Ethics 17: 8.  
 
Kinman, Gail, and Kevin Teoh. 2018. What could make a difference to the mental health of UK 
doctors? A review of the research evidence. London: Society of Occupational Medicine. 
 
Kirkham, Deborah, and Paul Baker. 2012. Twelve tips for running teaching programmes for newly 
qualified doctors. Medical Teacher 34: 625-630. 
 
Lamiani, Giulia, Lidia Borghi, and Piergiorgio Argentero. 2017. When healthcare professionals cannot 
do the right thing: A systematic review of moral distress and its correlates. Journal of Health 
Psychology 22: 51-67. 
 
Larcher, Victor F., Bryan Lask, and Jean M. McCarthy. 1997. Paediatrics at the cutting edge: Do we 
need clinical ethics committees? Journal of Medical Ethics 23: 245-249. 
 
Launer, John. 2018. Managing the threat to reflective writing. Postgraduate medical journal 94: 314-
315. 
 
Levine, Myra E. 1977. Nursing ethics and the ethical nurse. The American Journal of Nursing 77: 845-
849. 
 
Levy, Jeremy, and Bob Coward. 2010. Ethical dilemmas: A focus of discussion for junior 
doctors. Postgraduate Medical Journal 86: 631-631. 
 
Linklater, Gordon T. 2010. Educational needs of foundation doctors caring for dying patients. Journal 
of the Royal College of Physicians of Edinburgh 40: 13-18. 
 
London, Alex John. 2000. Amenable to reason: Aristotle’s Rhetoric and the moral psychology of 
practical ethics. Kennedy Institute of Ethics Journal 10: 287 – 305. 
 
MacRae, Susan K., Ellen Fox, and Anne Slowther. 2008. Clinical ethics and systems thinking. In The 
Cambridge textbook of bioethics, eds. Peter A. Singer and Adrian M. Viens, 313 – 321. Cambridge: 
Cambridge University Press.  
 
McClimans, Leah M., Michael Dunn, and Anne‐ Marie Slowther. 2011. Health policy, patient-centred 
care and clinical ethics. Journal of Evaluation in Clinical Practice 17: 913-919. 
 
McClimans, Leah, Anne-Marie Slowther, and Michael Parker. 2012. Can UK clinical ethics 
committees improve quality of care? HEC Forum 24: 139-147.  
 
McCruden, Patrick, and Mark Kuczewski. 2006. Is organizational ethics the remedy for failure to 
thrive? Toward an understanding of mission leadership. HEC Forum 18: 342 - 348. 
 
McDougall, Rosalind, and Daniel K. Sokol. 2008. The ethical junior: A typology of ethical problems 
faced by house officers. Journal of the Royal Society of Medicine 101: 67-70. 
 17 
 
McGee, Glenn, Joshua P. Spanogle, Arthur L. Caplan, and David A. Asch. 2001. A national study of 
ethics committees. American Journal of Bioethics 1: 60-64. 
 
McLean, Sheila AM. 2009. Clinical ethics consultation in the United Kingdom. Diametros 22: 76-89. 
 
Macdonald, Alistair and Worthington, Roger. 2012. The role of clinical ethics in the health care system 
of New Zealand: https://www.hqsc.govt.nz/assets/Other-Topics/QS-challenge-reports/Clinical-Ethics-
Network-Final-Report.pdf Accessed 5 June 2019.  
 
Machin, Laura L., Kieran M. Bellis, Clare Dixon, Hannah Morgan, Jane Pye, Phil Spencer, and 
Richard A. Williams. 2019. Interprofessional education and practice guide: Designing ethics-orientated 
interprofessional education for health and social care students. Journal of Interprofessional Care 33: 
608 - 618.  
 
Machin, Laura L., Natalie Latcham, Claire Lavelle, Richard. A. Williams, and Lorraine Corfield. 2020. 
Exploring the perceived medical ethics and law training needs of UK foundation doctors. Medical 
Teacher 42: 92 – 100. 
 
 
Magelssen, Morten, Reidar Pedersen, and Reidun Førde. 2016. Novel paths to relevance: how clinical 
ethics committees promote ethical reflection. HEC Forum 28: 205-216.  
 
Mayor, Susan. 2005. Clinicians need better access to ethics advice, report says. British Medical 
Journal 330:1345. 
 
Mills, Ann E., Patricia Tereskerz, and Walt Davis. 2005. Is evaluating ethics consultation on the basis 
of cost a good idea? Cambridge Quarterly of Healthcare Ethics 14: 57-64. 
 
Millstone, Michael. 2014. Teaching Medical Ethics to Meet the Realities of a Changing Health Care 
System. Bioethical Inquiry 11: 213 – 221. 
 
Molewijk, Bert., Anne Slowther, and Jan Schildmann. 2016. The European clinical ethics network: the 
professional development of clinical ethics support in Europe and the importance of quality assessment 
through evaluation research. Bioethica Forum  9: 86-9. 
 
Morley, Georgina, Jonathan Ives, and Caroline Bradbury-Jones. 2019. Moral distress and austerity: An 
avoidable ethical challenge in healthcare. Health Care Analysis 27: 185-201. 
 
Nelson, William A., William B. Weeks, Justin M. Campfield. 2008. The organizational costs of ethical 
conflicts. Journal of Healthcare Management 53: 41 – 52. 
 
Nelson, William A. 2009. Ethical uncertainty and staff stress. Moral distress has negative 
consequences for healthcare organizations. Healthcare Executive 24: 38 – 39.  
 
Nelson, William A., Paul B. Gardent, Eliza Shulman, and Mark E. Splaine. 2010. Preventing ethics 
conflicts and improving healthcare quality through system redesign. British Medical Journal Quality 
and Safety 19: 526-530. 
 
New South Wales Government Health. 2015. Clinical ethics support: Literature review. 
https://www.health.nsw.gov.au/clinicalethics/Publications/clinical-ethics-literature-review.pdf 
Accessed 5 June 2019.  
 18 
 
Nuffield Council on Bioethics. 2014. Ethics in the medical undergraduate curriculum: encouraging 
thinking in the midst of cramming facts http://nuffieldbioethics.org/blog/ethics-medical-undergraduate-
curriculum-encouraging-thinking-midst-cramming Accessed 24 April 2019.  
 
Oliver, David. 2018. Moral distress in hospital doctors. British Medical Journal 360: k1333. 
 
Orlowski, James P., S. Hein, J. A. Christensen, R. Meinke, and Terry Sincich. 2006. Why doctors use 
or do not use ethics consultation. Journal of Medical Ethics 32: 499-503. 
 
Papanikitas, Andrew. 2018. Accounting for ethics: Is there a market for morals in healthcare? In 
Marketisation, ethics and healthcare: Policy, practice and moral formation, eds. Therese Feiler, 
Joshua Hordern, Andrew Papanikitas, 174 – 193. London: Routledge.  
 
Pedersen, Reidar, Victoria Akre, and Reidun Førde. 2009. Barriers and challenges in clinical ethics 
consultations: The experiences of nine clinical ethics committees. Bioethics 23: 460-469. 
 
Pellegrino, Edmund D. 1989. Teaching medical ethics: Some persistent questions and some responses. 
Academic Medicine 64: 701 – 703. 
 
Racine, E. and Hayes, K., 2006. The need for a clinical ethics service and its goals in a community 
healthcare service centre: A survey. Journal of Medical Ethics 32: 564-566. 
http://dx.doi.org/10.1136/jme.2005.014589 
 
Reiser, Stanley Joel. 1994. The ethical life of health care organizations. Hastings Center Report 24: 28-
35. 
 
Repenshek, Mark. 2017. Assessing ROI for Clinical Ethics Consultation Services. 
https://www.chausa.org/docs/default-source/hceusa/assessing-roi-for-clinical-ethics-consultation-
services.pdf?sfvrsn=2 Accessed 26 April 2019. 
 
Rogers, Everett M. 1983. Diffusion of innovations. (3rd ed). New York: The Free Press.  
 
Rosner, Fred. 1985. Hospital medical ethics committees: A review of their development. Journal of 
American Medical Association 253: 2693-2697. 
Royal College of Physicians. 2005. Ethics in practice: Background and recommendations for enhanced 
support. London: Royal College Physicians.  
Rubin, Susan B., and Laurie Zoloth. 2004. Clinical ethics and the road less taken: Mapping the future 
by tracking the past. The Journal of Law, Medicine and Ethics 32: 218-225. 
 
Schildmann, Jan, Bert Molewijk, Lazare Benaroyo, Reidun Forde, and Gerald Neitzke. 2013. 
Evaluation of clinical ethics support services and its normativity. Journal of Medical Ethics 39: 681-
685. 
 
Schneiderman, Lawrence J., Todd Gilmer, Holly D. Teetzel, Daniel O. Dugan, Jeffrey Blustein, Ronald 
Cranford, Kathleen B. Briggs, Glen I. Komatsu, Paula Goodman-Crews, Felicia Cohn, and Ernlé W. 
Young. 2003. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive 
care setting: A randomized controlled trial. Journal of American Medical Association 290: 1166-1172. 
 
 19 
Seedhouse, David. 2009. Ethics: The heart of health care. London: Wiley-Blackwell. 
 
Simon, Alfred. 2001. Ethics committees in Germany: An empirical survey of Christian hospitals. HEC 
Forum 13: 225-231. 
 
Singer, Peter., Siegler, Mark., and Pellegrino, Edmund. 1990. Research in clinical ethics. The Journal 
of Clinical Ethics 1: 95-99. 
 
Singer, Peter A., Pellegrino, Edmund. D., and Siegler, Mark. 2001. Clinical ethics revisited. BMC 
Medical Ethics 2: 1 https://doi.org/10.1186/1472-6939-2-1 
 
Slowther, Anne, Chris Bunch, Brian Woolnough, and Tony Hope. 2001. Clinical ethics support 
services in the UK: An investigation of the current provision of ethics support to health professionals in 
the UK. Journal of Medical Ethics 27: i2-i8. 
 
Slowther, Anne Marie, Leah McClimans, and Charlotte Price. 2012. Development of clinical ethics 
services in the UK: A national survey. Journal of Medical Ethics 38: 210-214. 
 
de Snoo‐ Trimp, Janine, Guy Widdershoven, Mia Svantesson, Riekie De Vet, and Bert Molewijk. 
2017. What outcomes do Dutch healthcare professionals perceive as important before participation in 
moral case deliberation?. Bioethics 31: 246-257. 
 
Sokol, Daniel K. 2005. Meeting the ethical needs of doctors: We need clinical ethicists in addition to 
other measures. British Medical Journal 330: 741 - 742. 
 
Sokol, Daniel K. 2009. The unpalatable truth about ethics committees. British Medical Journal 339: 
b4179. 
 
Sokol, Daniel K. 2010. What to tell junior doctors about ethics. British Medical Journal 340: c2489. 
 
Solomon, Mildred Z., Bruce Jennings, Vivian Guilfoy, Rebecca Jackson, Lydia O'Donnell, Susan M. 
Wolf, Kathleen Nolan, Dieter Koch-Weser, and Strachan Donnelley. 1991. Toward an expanded vision 
of clinical ethics education: From the individual to the institution. Kennedy Institute of Ethics 
Journal 1: 225-245. 
 
Somerville, Margaret A. 2004. The ethics of clinical ethics services. The Medical Journal of 
Australia 181: 180-181. 
 
Steinkamp, Norbert, Bert Gordijn, Ana Borovecki, Eugenijus Gefenas, Jozef Glasa, Marc Guerrier, 
Tom Meulenbergs, Joanna Różyńska, and Anne Slowther. 2007. Regulation of health care ethics 
committees in Europe. Medicine, Health care and Philosophy 10: 461 – 475. 
 
Stirrat, Gordon M. 2015. Reflections on learning and teaching medical ethics in UK medical schools. 
Journal of Medical Ethics 41: 8 -11. 
 
Sulmasy, Daniel P. 2001. On the current state of clinical ethics. Pain Medicine 2: 97-105. 
 
Tarzian, Anita J., and American Society for Bioethics and Humanities Core Competencies Update Task 
Force. 2013. Health care ethics consultation: An update on core competencies and emerging standards 
from the American Society for Bioethics and Humanities’ Core Competencies Update Task Force. The 
American Journal of Bioethics 13: 3-13. 
 20 
 
Thomasma, David C. 1994. Clinical ethics as medical hermeneutics. Theoretical Medicine and 
Bioethics 15: 93-111. 
 
Thornton, J.G. and Lilford, R.J., 1995. Clinical ethics committee. British Medical Journal 311: 667. 
Doi: 10.1136/bmj.311.7006.667 
 
Tierney, William M., Paul R. Dexter, Gregory P. Gramelspacher, Anthony J. Perkins, Xiao‐ Hua Zhou, 
and Fredric D. Wolinsky. 2001. The effect of discussions about advance directives on patients’ 
satisfaction with primary care. Journal of General Internal Medicine 16: 32–40. 
 
Tulsky, James A., and Ellen Fox. 1996. Evaluating ethics consultation: Framing the questions. Journal 
of Clinical Ethics 7: 109-115. 
 
UK Clinical Ethics Network. A practical guide to clinical ethics support. 
http://www.ukcen.net/education_resources/support_guide/section_a_clinical_ethics_support Accessed 
4 December 2019.  
 
UK Clinical Ethics Network. 2014. Recognising, Preventing and Resolving Ethical Dilemmas in 
Health Care: The Need for Clinical Ethics Support in the NHS. 
http://www.ukcen.net/uploads/docs/general/Developing_Ethics_Support_in_the_NHS_UKCEN_case_
2014.pdf Accessed 17 May 2019. 
 
Verschoor, Curtis C. 1999. Corporate performance is closely linked to a strong ethical commitment. 
Business and Society Review 104: 407–416. 
 
Walker, Margaret U. 1993. Keeping moral space open: New images of ethics consulting. Hastings 
Center Report 23: 33-40. 
 
Weatherall, David J. 1994. The inhumanity of medicine. British Medical Journal 309: 1671. 
 
Weidema, Froukje, Hans van Dartel, and Bert Molewijk. 2016. Working towards implementing moral 
case deliberation in mental healthcare: Ongoing dialogue and shared ownership as strategy. Clinical 
Ethics 11: 54 – 62.  
 
Whitehead, Jessica M., Daniel K. Sokol, Deborah Bowman, and Phillip Sedgwick. 2009. Consultation 
activities of clinical ethics committees in the United Kingdom: An empirical study and wake-up 
call. Postgraduate Medical Journal 85: 451-454. 
 
Wilkerson, L., and Joseph A. Maxwell. 1988. A qualitative study of initial faculty tutors in a problem-
based curriculum. Journal of Medical Education 63: 892 – 899. 
 
 
 
